Global and Country-Level Analysis of Liver Cancer: Disease Burden and Recent Trends
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Liver cancer remains a major global health threat, causing over 750,000 deaths annually. Rising metabolic factors contribute to increasing incidence, necessitating targeted public health interventions.
Area Of Science
- Global Health
- Oncology
- Epidemiology
Background
- Liver cancer ranks as the sixth most common cancer worldwide and the third leading cause of cancer-related mortality.
- Over 750,000 deaths annually highlight the significant global public health challenge posed by liver cancer.
- Understanding current trends in liver cancer incidence and mortality is crucial for informing public health policies and clinical practices.
Purpose Of The Study
- To evaluate the updated global burden of liver cancer.
- To analyze recent trends in liver cancer incidence and mortality.
- To provide insights for public health policy and clinical practice improvements.
Main Methods
- Data sourced from the Global Burden of Disease Study 2021 (GBD 2021).
- Liver cancer incidence and mortality estimated using the Cause of Death Ensemble (CODEm) model.
- Temporal trends analyzed using linear regression and Estimated Annual Percentage Change (EAPC).
Main Results
- In 2021, 529,000 new liver cancer cases were diagnosed, with an age-standardized incidence rate (ASIR) of 6.15 per 100,000.
- Metabolic factors are increasingly contributing to liver cancer incidence.
- Higher incidence observed in males and older populations, with significant regional variations in burden.
Conclusions
- Liver cancer continues to be a substantial global public health concern.
- Targeted interventions are essential to address infectious and non-infectious drivers across diverse socioeconomic settings.
- Prevention strategies including vaccination, antiviral therapies, and metabolic disease management are critical for future burden reduction.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...